Subsidiary of Northeast Pharmaceutical Group (000597.SZ) Obtains Registration Certificate for Levitracetam Sustained-Release Tablets

Northeast Pharmaceutical Group (000597.SZ) announced that its wholly-owned subsidiary, Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd., recently received the Drug Registration Certificate issued by the National Medical Products Administration for their product: Levetiracetam Extended-release Tablets. This medication is used for the adjunctive treatment of partial-onset seizures in patients aged 12 and above. Obtaining the Drug Registration Certificate for Levetiracetam Extended-release Tablets will help enrich the company's product pipeline, enhance its market competitiveness, and bring new market opportunities.